TCG Crossover Management, LLC Q1 2025 Filing
Filed May 14, 2025
Portfolio Value
$733.1B
Holdings
38
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (38 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | CGONCG ONCOLOGY INC | 3,670,206 | $89.9B | 12.26% | |
| 2 | COGTCOGENT BIOSCIENCES INC | 6,964,375 | $41.7B | 5.69% | |
| 3 | CNTACENTESSA PHARMACEUTICALS PLC | 2,890,816 | $41.6B | 5.67% | |
| 4 | MLYSMINERALYS THERAPEUTICS INC | 2,470,265 | $39.2B | 5.35% | |
| 5 | OCULOCULAR THERAPEUTIX INC | 5,319,148 | $39.0B | 5.32% | |
| 6 | ABVXABIVAX SA AMERICAN DEPOSITARY SHARES | 6,056,596 | $37.9B | 5.16% | |
| 7 | YB4PSAVARA INC | 12,362,205 | $34.2B | 4.67% | |
| 8 | DYNDYNE THERAPEUTICS INC | 2,650,150 | $27.7B | 3.78% | |
| 9 | DNTHDIANTHUS THERAPEUTICS INC | 1,501,624 | $27.2B | 3.72% | |
| 10 | TYRATYRA BIOSCIENCES INC | 2,898,103 | $27.0B | 3.68% | |
| 11 | XNCRXENCOR INC | 2,452,138 | $26.1B | 3.56% | |
| 12 | IRONDISC MEDICINE INC | 465,257 | $23.1B | 3.15% | |
| 13 | TRMLTOURMALINE BIO INC | 1,477,593 | $22.5B | 3.07% | |
| 14 | CDTXCIDARA THERAPEUTICS INC | 1,005,901 | $21.7B | 2.96% | |
| 15 | AMLXAMYLYX PHARMACEUTICALS INC | 5,943,812 | $21.0B | 2.87% | |
| 16 | SLNOSOLENO THERAPEUTICS INC | 275,000 | $19.6B | 2.68% | |
| 17 | EYPTEYEPOINT PHARMACEUTICALS INC | 3,572,335 | $19.4B | 2.64% | |
| 18 | GPCRSTRUCTURE THERAPEUTICS INC | 1,063,000 | $18.4B | 2.51% | |
| 19 | UPBUPSTREAM BIO INC | 2,801,763 | $17.1B | 2.34% | |
| 20 | RAPTEURRAPT Therapeutics, Inc. | 13,090,200 | $16.0B | 2.18% | |
| 21 | FULCFULCRUM THERAPEUTICS INC | 5,250,000 | $15.1B | 2.06% | |
| 22 | CATBUSDASTRIA THERAPEUTICS INC | 2,761,861 | $14.7B | 2.01% | |
| 23 | TNGXTANGO THERAPEUTICS INC | 10,736,000 | $14.7B | 2.01% | |
| 24 | CMPSCOMPASS PATHWAYS LTD | 3,858,000 | $11.0B | 1.51% | |
| 25 | KURAKURA ONCOLOGY INC | 1,423,642 | $9.4B | 1.28% | |
| 26 | THRDTHIRD HARMONIC BIO INC | 2,505,424 | $8.7B | 1.19% | |
| 27 | SLNSILENCE THERAPEUTICS PLC | 3,033,560 | $8.6B | 1.17% | |
| 28 | AVU0ADVERUM BIOTECHNOLOGIES INC | 1,796,482 | $7.9B | 1.07% | |
| 29 | VTGNVISTAGEN THERAPEUTICS INC | 2,676,580 | $6.7B | 0.91% | |
| 30 | AVTEAEROVATE THERAPEUTICS INC | 2,240,809 | $5.6B | 0.77% | |
| 31 | TRDAENTRADA THERAPEUTICS INC | 584,955 | $5.3B | 0.72% | |
| 32 | MBXMBX BIOSCIENCES INC | 650,000 | $4.8B | 0.65% | |
| 33 | AVTXAVALO THERAPEUTICS INC | 483,000 | $3.9B | 0.53% | |
| 34 | KODKODIAK SCIENCES INC | 1,145,538 | $3.2B | 0.44% | |
| 35 | NKTREURNEKTAR THERAPEUTICS | 4,000,000 | $2.7B | 0.37% | |
| 36 | VTYXVENTYX BIOSCIENCES INC | 316,195 | $363.6M | 0.05% | |
| 37 | CABACABALETTA BIO INC | 86,795 | $120.2M | 0.02% | |
| 38 | KROSKEROS THERAPEUTICS INC | 0 | $0 | 0.00% |